研究成果 (130)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/2

3 A B C D E F G H I L M N O P Q R S T U 全部

30 Immunotherapy in advanced NSCLC - from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)
de Marinis F, Ciardiello F, Baas P, Crinò L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz-Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C ( 2018 )
ESMO Open
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1136/esmoopen-2017-000298
Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization
Simon Chun Ho Yu, Stephen Lam Chan, Kit Fai Lee, Joyce Wai Yi Hui, Edwin Pun Hui, Cheuk Man Chu, Anthony Wing-hung Chan, Sunny Cheung, Leung Li, John Wong, Winnie Ming Ming Yeo ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1148/radiol.2017170154
Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer
Lei YY, Ho SC, Cheng A, Kwok C, Lee CI, Cheung KL, Lee R, Loong HHF, He YQ, Yeo W ( 2018 )
Journal of the National Comprehensive Cancer Network
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.6004/jnccn.2017.7202
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Mann H, Andersohn F, Bodnar C, Mitsudomi T, Mok TSK, Yang JC, Hoyle C ( 2018 )
Clinical Drug Investigation
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s40261-017-0611-3
A feasibility study on using tablet personal computers for self‐reported symptom assessment in newly diagnosed lung cancer patients
Fiona W.K. Tang, Carmen W.H. Chan, Yin‐Ping Choy, Herbert H.F. Loong, Ka Ming Chow, Winnie K.W. So ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1111/ijn.12658
A feasibility study to evaluate the relationships between endocrine symptoms, drug adherence and genetic polymorphisms in breast cancer patients receiving tamoxifen therapy
Chan C. W. H., Alexandra McCarthy A., Chan J. Y. W., Chow K. M., Waye M. M.Y., Tsui S. K. W., Yeo W., Choi K. C., So W. K. W., Soo W., Miaskowski C. ( 2018 )
Refereed conference paper presented and published in conference proceedings
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study
Li J, Xu RH, Qin SK, Liu TS, Pan HM, Xu JM, Bi F, Lim R, Zhang SZ, Ba Y, Bai YX, Fan NF, Tsuji A, Yeh KH, Ma B, Wei V, Shi DM, Magherini E, Shen L, Shen L ( 2018 )
Future Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.2217/fon-2017-0669
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
Charing Ching-Ning Chong, Anthony Wing-Hung Chan, John Wong, Cheuk-Man Chu, Stephen Lam Chan, Kit-Fai Lee, Simon Chun-Ho Yu, Ka-Fai To, Philip Johnson, Paul Bo-San Lai ( 2018 )
Surgeon
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.surge.2017.07.003
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD ( 2018 )
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.77.7847
Analysis of Resistance Mechanisms to Osimertinib in Patients with EGFR T790M Advanced NSCLC from the AURA3 Study
V A Papadimitrakopoulou, Y-L Wu, J-Y Han, M-J Ahn, S S Ramalingam, T John, I Okamoto, J C-H Yang, K C Bulusu, G Laus, B Collins, J C Barrett, J Chmielecki, T S K Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdy424.064
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B.Y. Ma, Wan-Teck Lim, Boon-Cher Goh, Edwin P. Hui, Kwok-Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y.C. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean W. Lim, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.C. Chan ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.77.0388
A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers
Alexander E. Drilon, Vivek Subbiah, Geoffrey R. Oxnard, Todd Michael Bauer, Vamsidhar Velcheti, Nehal J. Lakhani, Benjamin Besse, Keunchil Park, Jyoti D. Patel, Maria E. Cabanillas, Melissa Lynne Johnson, Karen L. Reckamp, Valentina Boni, Herbert H. F. Loong, Martin Schlumberger, Ben Solomon, Scott Cruickshank, Stephen M. Rothenberg, Manisha H. Shah, Lori J. Wirth ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.102
A pilot case-control study of second or third-line treatment with cetuximab-containing chemotherapy (cetux-chemo) in patients (pts) with metastatic colorectal cancer (mCRC) who were previously treated with cetux-chemo
Ho CS, Cheng AC, Li L, Ho WM, Hui EP, To KF, Tong JHM, Ma BBY ( 2018 )
ANNALS OF ONCOLOGY
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdy431.022
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study
Abou-Alfa GK, Chan SL, Furuse J, Galle PR, Kelley RK, Qin SK ( 2018 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS4144
Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma
Chan AWH, Tong JHM, Kwan JSH, Chow C, Chung LY, Chau SL, Lung RWM, Ng CSH, Wan IYP, Mok TSK, To KF ( 2018 )
Modern Pathology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41379-018-0053-3
Association Between Serum Folate Level and Toxicity of Capecitabine During Treatment for Colorectal Cancer
Chan SL, Chan AWH, Mo F, Ma BBY, Wong KCW, Lam D, Mok FST, Chan ATC, Mok T, Chan KCA ( 2018 )
The oncologist
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1634/theoncologist.2017-0637
Association of serum folate level with toxicity of capecitabine in patients with colorectal cancers: a prospective cohort study.
Chan SL, Ma BB, Chan AK ( 2018 )
Hong Kong medical journal = Xianggang yi xue za zhi
Publication in refereed journal
A statistical model for survival risk prediction in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment
Berhane S, Fox R, Chan SL, Yau T, Johnson P ( 2018 )
JOURNAL OF HEPATOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S0168-8278(18)30607-X
ATOM: A Phase II Study to Assess Efficacy of Preemptive Local Ablative Therapy to Residual Oligometastases After EGFR TKI
Oscar S.H. Chan, Kwok Chi Lam, Jacky Yu Chung Li, Frankie Choi, Catherine Wong, Amy Chang, Frankie Mo, Ki Wang, Rebecca Yeung, Tony S. Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.270
AXL and CDCP1: A roadmap of innate resistance in EGFR mutant NSCLC
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona Zorrilla, Jordi Berenguer, Jillian Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Ana Drozdowskyj, Ilaria Attili, July Katherine Rodríguez, Luis Leonardo Rojas Puentes, Santiago Viteri Ramirez, Sai-Hong Ignatius Ou, Tony Mok, Trever Grant Bivona, Mayumi Ono, Jingrong Jean Cui, Peng Cao, Rafael Rosell ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.e24003
Baseline gene expression patterns of CDK4/6 inhibitor-naïve or -refractory HR+, HER2-negative advanced breast cancer in the Phase Ib study of ribociclib plus everolimus plus exemestane (Abstract poster 10756)
Aditya Bardia, Shanu Modi, Javier Cortes, Mario Campone, Luc Dirix, Brigette Ma, J Thaddeus Beck, Jorge Chaves, Amy Weise, Jacqueline Vuky, Gilberto Lopes, Miguel Gil-Gil, Xiaochun Liu, Wei He, Faye Su, Michelle Miller, Mariana Chavez-MacGregor ( 2018 )
Invited conference paper presented and published in conference proceedings
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
David R. Gandara, Sarah M. Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf, Daniel S. Lieber, Doron Lipson, Jacob Silterra, Lukas Amler, Todd Riehl, Craig A. Cummings, Priti S. Hegde, Alan Sandler, Marcus Ballinger, David Fabrizio, Tony Mok, David S. Shames ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41591-018-0134-3
Bone health in premenopausal Chinese patients after adjuvant chemotherapy for early breast cancer
W Yeo, GS Liem, J Suen, E Pang, R Ng, CHW Yip, FKF Mo ( 2018 )
Refereed conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S0959-8049(18)30379-4
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial
Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Park JW, Blanc JF, Bolondi L, Klumpen HJ, Chan SL, Dadduzio V, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK ( 2018 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.4_suppl.207
Changes in body weight over 18-months follow-up among Chinese patients after breast cancer diagnosis
Yeo W, Lei YY, Cheng AC, Kwok CC, Cheung KL, Lee IC, Lee R, Ho S ( 2018 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdy270.251
Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
Geoffrey R. Oxnard, Vivek Subbiah, Keunchil Park, Todd M. Bauer, Lori J Wirth, Vamsidhar Velcheti, Manisha Shah, Benjamin Besse, Valentina Boni, Karen L. Reckamp, Herbert H Loong, Lyudmila Bazhenova, Ben J Solomon, Daniel S.W. Tan, Jyoti Patel, Melissa L. Johnson, Anas Gazzah, Tony S. Mok, Steve Smith, Brian Tuch, Kevin Ebata, Edward Y Zhu, Michele M Nguyen, Xin Huang, Scott Cruickshank, S Michael Rothenberg, Alexander Drilon ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.304
Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia
Loong HH, Raymond VM, Shiotsu Y, Chua DTT, Teo PML, Yung T, Skrzypczak S, Lanman RB, Mok TSK ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.cllc.2018.04.022
CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3)
Wu YL, Ahn MJ, Garassino MC, Han JY, Katakami N, Kim HR, Hodge R, Kaur P, Brown AP, Ghiorghiu D, Papadimitrakopoulou VA, Mok TSK ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.77.9363
Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-Small Cell Lung Cancer Associated With Poor Prognosis
Niki Karachaliou, Imane Chaib, Andres Felipe Cardona, Jordi Berenguer, Jillian Wilhelmina Paulina Bracht, Jie Yang, Xueting Cai, Zhigang Wang, Chunping Hu, Ana Drozdowskyj, Carles Codony Servat, Jordi Codony Servat, Masaoki Ito, Ilaria Attili, Erika Aldeguer, Ana Gimenez Capitan, July Rodriguez, Leonardo Rojas, Santiago Viteri, Miguel Angel Molina-Vila, Sai-Hong Ignatius Ou, Morihito Okada, Tony S. Mok, TreverG.Bivona, Mayumi Ono, Jean Cui, Santiago Ramón y Cajal, Alex Frias, Peng Cao, Rafael Rosel ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
publication.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.ebiom.2018.02.001
Comparison of Immune Microenvironment in CD8-Rich and CD8-Poor Hepatocellular Carcinoma
Chan A, Chow C, Chan SL, Tong JH, To KF ( 2018 )
Laboratory Investigation
Publication in refereed journal
Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade
Wang Z, Zhao J, Wang G, Zhang F, Zhang Z, Zhang F, Zhang Y, Dong H, Zhao X, Duan J, Bai H, Tian Y, Wan R, Han M, Cao Y, Xiong L, Liu L, Wang S, Cai S, Mok TSK, Wang J ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/0008-5472.CAN-18-1814
Co-mutations of DNA damage response system as predictive biomarker for immune checkpoint blockades
Zhijie Wang, Jing Zhao, Guoqiang Wang, Fan Zhang, Yuzi Zhang, Hua Dong, Xiaochen Zhao, Jianchun Duan, Hua Bai, Yanhua Tian, Rui Wan, Lei Xiong, Shangli Cai, Tony Mok, Jie Wang ( 2018 )
Invited conference paper presented and published in conference proceedings
Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
Loong HH, Wong KH, Tse T ( 2018 )
ESMO OPEN
Publication in refereed journal
典藏於此文庫的全文:
output.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1136/esmoopen-2017-000293
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1093/neuonc/noy056
Cost-effectiveness of ceritinib in previously untreated ALK-positive advanced non-small cell lung cancer in Hong Kong
H.H. Loong, C.K..H. Wong, L.K..S. Leung, C.P.K. Chan, A. Chang, M. Gibbs ( 2018 )
Invited conference paper presented and published in conference proceedings
Cost-Effectiveness of Screening for Nasopharyngeal Carcinoma with Plasma Epstein-Barr Virus DNA
Harris JP, Saraswathula A, Kaplun BD, Qian Y, Chan KCA, Chan ATC, Le QT, Owens D, Goldhaber-Fiebert JD, Pollom E ( 2018 )
International Journal of Radiation Oncology Biology Physics
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.ijrobp.2018.07.1184
Dacomitinib (daco) versus gefitinib (gef) for first-line treatment of advanced NSCLC (ARCHER 1050): Final overall survival (OS) analysis
Tony Mok, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Min Young Lee, Rolf Gerhard Linke, Rafael Rosell, Jesus Corral Jaime, Maria Rita Migliorino, Adam Pluzanski, Eric I Sbar, Tao Wang, Jane Liang White, Yi-Long Wu ( 2018 )
Invited conference paper presented and published in conference proceedings
Dietary changes in the first 3 years after breast cancer diagnosis: a prospective Chinese breast cancer cohort study
Lei YY, Ho SC, Cheng A, Kwok C, Cheung KL, He YQ, Lee CI, Lee R, Yeo W ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
dietary-changes.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.2147/CMAR.S168562
Dietary soy intake and mortality outcome in Chinese breast cancer survivors
Ho S, Yeo W, Cheng ACK, Kwok CCH, Lee R, Lee ICK, Cheung CKL, Sham A, Ip A, Lei YY, He YQ ( 2018 )
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Refereed conference paper presented and published in conference proceedings
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion weighted MRI - Scientific Poster Presentation
Ai QY, Chan JSM, Chen W, Chan AKC, Woo JKS, Zee BCY, Chan ATC, Poon DMC, Ma BBY, Hui EP, Ahuja AT, Vlantis AC, King AD ( 2018 )
Other conference paper
Early clearance of plasma EGFR mutations as a predictor of response to osimertinib in the AURA3 trial
Frances A. Shepherd, Vassiliki Papadimitrakopoulou, Tony Mok, Yi-Long Wu, Ji-Youn Han, Myung-Ju Ahn, Suresh S. Ramalingam, Tom John, Martin Sebastian, Willemijn Theelen, Gianluca Laus, Barbara Collins, Aleksandra Markovets, Kenneth S. Thress, Geoffrey R. Oxnard ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.9027
Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
Tony S. Mok, Kazuhiko Nakagawa, Rafael Rosell, Ki Hyeong Lee, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Rolf Linke, Geeta Devgan, Eric I. Sbar, Susan Quinn, Tao Wang, Yi-Long Wu ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.546
Efficacy and Safety of Nivolumab in Asian Patients With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study
Amy Ma, Su-Pin Choo, Chiun Hsu, Yoon-Koo Kang, Ming-Mo Hou, Winnie Yeo, Kazushi Numata, Akhil Chopra, Adyb Baakili, Christine dela Cruz, Huanyu Zhao, Masatoshi Kudo ( 2018 )
Refereed conference paper presented and published in conference proceedings
Efficacy and tolerability of trastuzumab emtansine in advanced human epidermal growth factor receptor 2–positive breast cancer
Yeo W, Luk MY, Soong IS, Yuen TY, Ng TY, Mo FK, Chan K, Wong SY, Tsang J, Leung C, Suen JJ, Ngan RK ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.12809/hkmj176808
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P. Hui, Brigette B. Y. Ma, Herbert H. F. Loong, Frankie Mo, Leung Li, Ann D. King, Ki Wang, Anil T. Ahuja, Charles M. L. Chan, Connie W. C. Hui, Chi H. Wong, Anthony T. C. Chan ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/1078-0432.CCR-17-1667
Enhancing the efficacy of liver cancer immunotherapy by specific inhibition of histone deacetylase 8
Weiqin YANG, Jingying ZHOU, Yu FENG, Hangyong SUN, Stephen L CHAN, Anthony W.H. CHAN, Zhiwei CHEN, Ka-Fai TO, Alfred Sze-Lok CHENG ( 2018 )
Refereed conference paper presented and published in conference proceedings
Epidemiology and Management Guidelines of Hepatocellular Carcinoma
Winnie Yeo ( 2018 )
Invited conference paper presented and published in conference proceedings
Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas
Lili Li, Juan Xu, Guohua Qiu, Jianming Ying, Zhenfang Du, Tingxiu Xiang, Kai Yau Wong, Gopesh Srivastava, Xiao-Feng Zhu, Tony S Mok, Anthony TC Chan, Francis KL Chan, Richard F Ambinder, Qian Tao ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.7150/thno.20893
Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas
Lili Li, Brigette B. Y. Ma, Anthony T. C. Chan, Francis K. L. Chan, Paul Murray, Qian Tao ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.3390/pathogens7030063
eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients
Leora Horn, Yi-Long Wu, Martin Reck, Heather A. Wakelee, Chris Liang, Fenlai Tan, Kimberly Harrow, Vance Oertel, Gary Dukart, Tony Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS9115
eXalt3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients
Leora Horn, Yi-Long Wu, Martin Reck, Heather A Wakelee, Chris Liang, Kimberly Harrow, Vance Oertel, Tony S. Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.858
EXALT3: Phase 3 Randomized Study Comparing Ensartinib to Crizotinib in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients
L. Horn, Y. Wu, M. Reck, H. Wakelee, C. Liang, K. Harrow, V. Oertel, T. Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
Extranodal spread is a predictor of poor outcome in nasopharyngeal carcinoma - Scientific Poster Presentation
Ai QY, Mo FKF, Poon DMC, Ahuja AT, Hui EP, Tong M, Ma BBY, Chan ATC, King AD ( 2018 )
Other conference paper
Factors predicting patient satisfaction in women with advanced breast cancer: a prospective study
Lam WWT, Kwong A, Suen D, Tsang J, Soong I, Yau TK, Yeo W, Suen J, Ho WM, Wong KY, Sze WK, Ng AWY, Fielding R ( 2018 )
Publication in refereed journal
典藏於此文庫的全文:
230 Paper breast pt satisfaction BMCCancer Lam 18-2.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1186/s12885-018-4085-3
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV, IMpower133 Study Group ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1056/NEJMoa1809064
FUS-NFATc2 sarcoma of bone, a novel molecular entity with aggressive behavior: Clinical and molecular pathology findings of two cases
M.D. Lacambra, H. Loong, K.F. To, X. Feng, G. Taylor, E. Pleasance, J. Laskin, M. Marra, J. Griffith, H.Y.M. Yeung, K. Wong, C. Chow, S. Kumta, W.H.A. Ng, T. Tse, C. Tong, T. Ng ( 2018 )
Invited conference paper presented and published in conference proceedings
Gene embedding: A novel machine learning approach to identify gene candidates related to immunotherapy responsiveness
Choy CT, Wong CH, Chan SL ( 2018 )
ANNALS OF ONCOLOGY
Publication in refereed journal
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
Xiangchun Li, Weiqi Xu, Wei Kang, Sunny H. Wong, Mengyao Wang, Yong Zhou, Xiaodong Fang, Xiuqing Zhang, Huanming Yang, Chi H. Wong, Ka F. To, Stephen L. Chan, Matthew T.V. Chan, Joseph J.Y. Sung, William K.K. Wu, Jun Yu ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.7150/thno.22010
Head and Neck Tumors: Amide Proton Transfer MRI
Benjamin King Hong Law, Ann D. King, Qi-Yong Ai, Darren M. C. Poon, Weitian Chen, Kunwar S. Bhatia, Anil T. Ahuja, Brigette B. Ma, David Ka-Wai Yeung, Frankie Kwok Fai Mo, Yi-Xiang Wang, Jing Yuan ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1148/radiol.2018171528
Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study
Tim Meyer, Ignacio Melero, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Su-Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon-Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine dela Cruz, Huanyu Zhao, Jaclyn Neely, odd S. Crocenzi, Anthony B. El-Khoueiry, Bruno Sangro ( 2018 )
Refereed conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S0168-8278(18)30249-6
Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation
Yue Y, Yuan Y, Li L, Fan J, Li C, Peng W, Ren G. ( 2018 )
International journal of molecular medicine
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/doi: 10.3892/ijmm.2018.3468
Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis
Patrick Kwok Shing NG, Carol Po Ying LAU, Emily Kai Yee LAM, Sheila Sai Kam LI, Vivian Wai Yan LUI, Winnie YEO, Yuen Keng NG, Paul Bo San LAI, Stephen Kwok Wing TSUI ( 2018 )
Digestive diseases and sciences
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s10620-018-4929-3
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
Lei-lei Niu, Chuan-le Cheng, Ming-Yue Li, Sheng-li Yang, Bao-guang Hu, Charing C. N. Chong,
Stephen L. Chan, Jianwei Ren, George G. Chen, Paul B. S. Lai ( 2018 )
Cell death & disease
Publication in refereed journal
典藏於此文庫的全文:
82437020.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1038/s41419-018-0926-x
Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions
Ross A. Soo, Sun Min Lim, Nicholas L. Syn, Rebecca Teng, Richie Soong, Tony S.K. Mok, Byoung Chul Cho ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.lungcan.2017.11.009
Immunotherapies of nasopharyngeal carcinoma
Ma B ( 2018 )
ANNALS OF ONCOLOGY
Invited conference paper presented and published in conference proceedings
Impact of primary tumor side on outcomes of every-2-weeks (q2w) cetuximab + first-line FOLFOX or FOLFIRI in patients with RAS wild-type (wt) metastatic colorectal cancer (mCRC) in the phase 2 APEC trial
Timothy Jay Price, Lin Shen, Brigette Ma, Regina Esser, Wen-Feng Chen, Peter Gibbs, Robert S.C. Lim, Ann-Lii Cheng ( 2018 )
Invited conference paper presented and published in conference proceedings
Impact of the EML4-ALK variant on the efficacy of alectinib (ALC) in untreated ALK+ advanced NSCLC (aNSCLC) in the global phase III ALEX study
R Dziadziuszko, T S Mok, D R Camidge, A T Shaw, J Noe, M Nowicka, T Liu, E Mitry, S Peters ( 2018 )
Invited conference paper presented and published in conference proceedings
IMpower 133: Primary PFS, OS and Safety in a PH1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in Extensive-Stage SCLC
Stephen V Liu, Aaron S. Mansfield, Aleksandra Szczesna, Libor Havel, Maciej Krzakowski, Maximilian Johannes Hochmair, Florian Huemer, Gyorgy Losonczy, Melissa L. Johnson, Makoto Nishio, Martin Reck, Tony S. Mok, Sivuonthanh Lam, David S. Shames, Juan Liu, Beiying Ding, Fairooz Kabbinavar, Wei Lin, Alan Sandler, Leora Horn ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.013
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib with Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations
Tony S. Mok, Ying Cheng, Xiangdong Zhou, Ki Hyeong Lee, Kazuhiko Nakagawa, Seiji Niho, Min Lee, Rolf Linke, Rafael Rosell, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Eric I. Sbar, Tao Wang, Jane Liang White, Yi-Long Wu ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018. 78.7994
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials
Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/1078-0432.CCR-17-2656
Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway
Ye, Xiang, Zhu, Li, Shao, Peng, Tang, Li, Ren ( 2018 )
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1159/000495399
Latest Treatment Approach on Hormonal Positive Breast Cancer
Yeo W ( 2018 )
Invited conference paper presented and published in conference proceedings
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DS, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.05.030
Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers With or Without Liver Metastases
Gai W, Ji L, Lam WKJ, Sun K, Jiang P, Chan AWH, Wong J, Lai PBS, Ng SSM, Ma BBY, Wong GLH, Wong VWS, Chan HLY, Chiu RWK, Lo YMD, Chan KCA ( 2018 )
Clinical chemistry
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1373/clinchem.2018.290304
Longitudinal study on incidences of obesity and weight changes in Chinese patients with early-stage breast cancer
Yeo W, Lei YY, Cheng AC, Kwok CC, Cheung KL, Lee R, Lee IC, He YQ, Ho S ( 2018 )
ANNALS OF ONCOLOGY
Refereed conference paper presented and published in conference proceedings
Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
Rudin C, Cervantes A, Dowlati A, Besse B, Ma B, Costa D, Schmid P, Heist R, Villaflor V, Sarkar I, Hernandez G, Foster P, Spahn J, O'Hear C, Gettinger S ( 2018 )
JOURNAL OF THORACIC ONCOLOGY
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtho.2018.08.440
Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection
Charing C.N. Chong, Kit-Fai Lee, Cheuk-Man Chu, Anthony W.H. Chan, John Wong, Stephen L. Chan, Hon-Ting Lok, Andrew K.Y. Fung, Anthony K.W. Fong, Yue S. Cheung, Simon C.H. Yu, Philip Johnson, Paul B.S. Lai ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.hpb.2017.12.001
MiR-133a is a predictive biomarker in patients with metastatic colorectal cancer receiving oxaliplatin-based chemotherapy
Ng SS, Dong Y, Leung WW, Ma BB, To KF, Sung JJ, Yu J ( 2018 )
Invited conference paper presented and published in conference proceedings
MR Imaging Criteria for the Detection of Nasopharyngeal Carcinoma: Discrimination of Early-Stage Primary Tumors from Benign Hyperplasia
King AD, Wong LYS, Law BKH, Bhatia KS, Woo JKS, Ai QY, Tan TY, Goh J, Chuah KL, Mo FKF, Chan KCA, Chan ATC, Vlantis AC. ( 2018 )
Publication in policy or professional journal
數位物件識別號 (DOI): http://dx.doi.org/10.3174/ajnr.A5493
Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastases
Qi-Yong Ai, Chen-Wen Hu, Kunwar S. Bhatia, Darren M. C. Poon, Edwin P. Hui, Frankie K. F. Mo, Benjamin King Hong Law, Macy Tong, Brigette B. Ma, Anthony T. C. Chan, Ann D. King ( 2018 )
Publication in policy or professional journal
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s00405-017-4825-z
NCCN-Clinical Practice Guidelines in Oncology (NCCN Guidelines®) - Non-Small Cell Lung Cancer - Asia Consensus Statements Version 2 [2018]
Tetsuya Mitsudomi, Keunchil Park, Yi-Long Wu, Jin-Haeng Chung, Jhingook Kim, Dongmei Lin, You Lu, Tony SK Mok, Kazuhiko Nakagawa, Yuko Nakayama, Takashi Seto, Ross Soo, Sumitra Thongprasert, Hong-Gyun Wu, Nobuyuki Yamamoto, James Chih-Hsin Yang, Yasushi Yatabe, Qing Zhou ( 2018 )
Other outputs
Neutrophils: driving progression and poor prognosis in Hepatocellular Carcinoma?
Jane Margetts, Laura F Ogle, Stephen L Chan, Anthony W H Chan, K C Allen Chan, David Jamieson, Catherine E Willoughby, Derek A Mann, Caroline L Wilson, Derek M Manas, Winnie Yeo, Helen L Reeves ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1038/bjc.2017.386
Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma
Charing Ching-Ning Chong, Siu Tim Cheung, Yue-Sun Cheung, Anthony Wing-Hung Chan, Stephen Lam Chan, Simon Chun-Ho Yu, Paul Bo-San Lai ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.hbpd.2018.10.003
Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma
Zhao ZR, Lau RWH, Long H, Mok TSK, Chen GG, Underwood MJ, Ng CSH ( 2018 )
The Journal of thoracic and cardiovascular surgery
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.jtcvs.2018.07.054
Optimal management of desmoid fibromatosis
Loong HHF ( 2018 )
HONG KONG MEDICAL JOURNAL
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.12809/hkmj187250
Outcomes by baseline alpha-fetoprotein (AFP) levels in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (HCC)
Kelley RK, El-Khoueiry AB, Meyer T, Rimassa L, Merle P, Chan SL, Tran A, Parnis F, Tam VC, Cattan S, Markby DW, Clary DO, Cheng AL, Abou-Alfa GK ( 2018 )
ANNALS OF ONCOLOGY
Publication in refereed journal
Outcomes in patients (pts) who had received sorafenib (S) as the only prior systemic therapy in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
Kelley RK, Ryoo BY, Merle P, Park JW, Bolondi L, Chan SL, Lim HY, Baron AD, Parnis F, Knox J, Cattan S, Yau TC, Lougheed J, Milwee S, El-Khoueiry A, Cheng AL, Meyer T, Abou-Alfa GK ( 2018 )
Journal of Clinical Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.4088
Overall Survival Results of Ceritinib in ALKi-Naïve Patients with ALK-Rearranged NSCLC (ASCEND-3)
E Felip, M Nishio, S Orlov, K Park, C-J Yu, C-M Tsai, M Cobo, M McKeage, W-C Su, T SK Mok, G V Scagliotti, D Spigel, V Q Passos, Z Chen, A T Shaw ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdy424.069
Overview of current systemic management of EGFR-mutant NSCLC
Hsu WH, Yang JCH, Mok TS, Loong HH ( 2018 )
ANNALS OF ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdx702
OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma
Qi XK, Han HQ, Zhang HJ, Xu M, Li L, Chen L, Xiang T, Feng QS, Kang T, Qian CN, Cai MY, Tao Q, Zeng YX, Feng L ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.7150/thno.24003
Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The AURA3 Trial
Chee Khoon Lee, Silvia Novello, Anna Rydén, Helen Mann, Tony Mok ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.77.2293
PD-L1 expression associated with treatment responses in colorectal cancer patients with XELOX/FOLFOX chemotherapy: potential of checkpoint blockage and natural killer cell-based immunotherapy
Siu EHL, Ng SSM, Chan AWH, Lau JYW, Lo KW, Chong CCN, Lai PBS, Chan SL, Law MHN, Ng LWC, Cheung ST ( 2018 )
Other conference paper
PD-L1 expression associated with treatment responses in colorectal cancer patients with XELOX/FOLFOX chemotherapy: Potential of checkpoint blockage and natural killer cell-based immunotherapy
Siu EHL, Ng SSM, Chan AWH, Lau JYW, Lo KW, Chong CCN, Lai PBS, Chan SL, Law MHN, Ng LWC, Cheung ST ( 2018 )
CANCER RESEARCH
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/1538-7445.AM2018-4563
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A, Sarker D, Verset G, Chan SL, Knox J, Daniele B, Webber AL, Ebbinghaus SW, Ma JS, Siegel AB, Cheng AL, Kudo M ( 2018 )
LANCET ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/S1470-2045(18)30351-6
Pembrolizumab (pembro) versus platinum-based chemotherapy (chemo) as first-line therapy for advanced/metastatic NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 1%: Open-label, phase 3 KEYNOTE-042 study
Gilberto Lopes, Yi-Long Wu, Iveta Kudaba, Dariusz Kowalski, Byoung Chul Cho, Gilberto Castro, Vichien Srimuninnimit, Igor Bondarenko, Kaoru Kubota, Gregory M. Lubiniecki, Jin Zhang, Debra A. Kush, Tony Mok ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.18_suppl.LBA4
Phase I Investigator’s Perceptions to ‘Supersized Seamless Trials in Oncology’
B B Y Ma, N van der Velden, F Mo, H H Loong, L Siu, B C Goh, Y-J Bang, C-C Lin, J Desai, M P Lolkema ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1093/annonc/mdy430.011
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Lim HY, Merle P, Weiss KH, Yau T, Ross P, Mazzaferro V, Blanc JF, Ma YT, Yen CJ, Kocsis J, Choo SP, Sukeepaisarnjaroen W, Gerolami R, Dufour JF, Gane EJ, Ryoo BY, Peck-Radosavljevic M, Dao T, Yeo W, Lamlertthon W, Thongsawat S, Teufel M, Roth K, Reis D, Childs BH, Krissel H, Llovet JM ( 2018 )
CLINICAL CANCER RESEARCH
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1158/1078-0432.CCR-17-3588
Physical activity and dietary changes in Chinese patients post breast cancer diagnosis
Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Chi-Kiu Iris Lee, Ka Li Cheung, Roselle Lee, Herbert HF Loong, Yi-Qian He, Winnie Yeo ( 2018 )
Invited conference paper presented and published in conference proceedings
Population pharmacokinetics (PopPK) and exposure-response (ER) analyses to confirm the global alectinib (ALC) 600mg BID dose in the Chinese treatment-naïve population
Joy Hsu, Felix Jaminion, Alice Shaw, Caicun Zhou, Tony Mok, Tomohide Tamura, Tomohiro Tanaka, Emmanuel Mitry, Elena Guerini, Eveline Nüesch, Bogdana Balas, Ali Hassan Zeaiter, Peter N. Morcos, Nicolas Frey ( 2018 )
Invited conference paper presented and published in conference proceedings
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.e21133
Potential skeletal side effects associated with adjuvant chemotherapy for premenopausal breast cancer patients
W Yeo, GS Liem, J Suen, E Pang, R Ng, CHW Yip, WH Ko, FKF Mo ( 2018 )
Invited conference paper presented and published in conference proceedings

10 | 25 | 50 | 100

1/2

研究成果 (130)

分享連結

Our policy towards the use of cookies